Organic Letters
Letter
previously been synthesized by nucleophilic radiofluorination
of ethyl bromodifluoroacetate 5 with [18F]KF/K2.2.2, followed
by reduction with AlH3 prepared in situ from LiAlH4 and
H2SO4 (Scheme 2B).25 The [18F]trifluoroethanol was not used
directly and required an additional step to generate [18F]-
trifluoroethyl triflate, which was then applied for amine
alkylation. Multiple distillations were used to purify ethyl
[18F]trifluoroacetate 7 and [18F]trifluoroethanol.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge at
■
sı
Experimental data, characterization data, 18F-radiotraces
AUTHOR INFORMATION
Corresponding Author
We sought to develop an [18F]trifluoroethanol synthesis
without distillation, using instead HPLC purification. We also
aimed to replace AlH3 with NaBH4, a reducing agent readily
available and easy to handle. Our initial experiments showed
that ethyl trifluoroacetate [18F]6 is unstable under reversed-
phase HPLC conditions. Therefore, we targeted menthol
[18F]trifluoroacetate [18F]9, an ester which is more resistant to
hydrolysis and therefore amenable to purification by reversed-
■
́
Veronique Gouverneur − Chemistry Research Laboratory,
Oxford University, Oxford OX1 3TA, U.K.; orcid.org/
Authors
Robert Szpera − Chemistry Research Laboratory, Oxford
University, Oxford OX1 3TA, U.K.
Patrick G. Isenegger − Chemistry Research Laboratory, Oxford
University, Oxford OX1 3TA, U.K.
Maxime Ghosez − Chemistry Research Laboratory, Oxford
University, Oxford OX1 3TA, U.K.
Natan J. W. Straathof − Chemistry Research Laboratory,
Oxford University, Oxford OX1 3TA, U.K.
Rosa Cookson − Medicines Research Centre, GlaxoSmithKline
plc, Stevenage, Hertfordshire SG1 2NY, U.K.
David C. Blakemore − Medicine Design, Pfizer Inc., Groton
Connecticut 06340, United States
Paul Richardson − Medicine Design, Pfizer Inc., San Diego,
California 92121, United States
phase HPLC (Scheme 2C). Under conditions slightly modified
26
́
from those previously reported by Szabo and Schou,
synthesis of [18F]9 was achieved in 27 10% radiochemical
yield (RCY) using [18F]TBAF and DBU in 1,3-dimethyl-2-
imidazolidinone (DMI).27 After HPLC purification and
reformulation into 1,4-dioxane, reduction using NaBH4
afforded [18F]trifluoroethanol in 98
1% RCY. Menthol,
formed during the reduction step, was found to be unreactive
under the conditions applied for C−O cross-coupling, and
therefore a purification step by filtration to remove salts was
sufficient. 1,4-Dioxane was used as the reaction solvent, as it
afforded high yields for the reduction (toluene performed
poorly) and proved highly suitable for the subsequent C−O
cross-coupling (Table 1, entry 10). This modification was
advantageous by avoiding a second reformulation step.
Under slightly modified coupling conditions, [18F]-
trifluoroethanol was coupled with aryl bromide 1a and
naphthyl bromide 1l to afford the desired cross-coupled
[18F]trifluoroethyl ethers (Scheme 2D). Radio-HPLC showed
clean reaction profiles, with mainly the 18F-labeled product and
unreacted [18F]trifluoroethanol. Extending the reaction
duration beyond 20 minutes did not increase the RCY. Our
study showed that the coupling was sensitive to the water
content in the [18F]trifluoroethanol solution; drying of
menthol [18F]trifluoroacetate [18F]9 under a flow of nitrogen
was essential prior to reformulation in 1,4-dioxane.27 While Pd-
mediated C−N and C−C cross-coupling has been used for
introduction of 18F-labeled motifs,28 this work supports the
feasibility of 18F-radiolabeling by Pd-mediated C−O cross-
coupling.
In conclusion, we have developed a protocol for Pd-
catalyzed cross-coupling between fluorinated alcohols and
(hetero)aryl bromides using the mild base Cs2CO3; the
reaction tolerates various electronic patterns on the arene ring,
a wide range of functional groups including those with mildly
acidic α-protons, and proceeds over a short duration. An
activated aryl chloride has also been shown to couple
effectively. In addition, K3PO4 was found to be a cheaper
alternative base to Cs2CO3. The utility of the coupling has
been further demonstrated with a new disconnection approach
to 18F-labeled trifluoroethyl ethers consisting of C−O cross-
coupling of aryl bromides with [18F]trifluoroethanol.
Complete contact information is available at:
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We acknowledge the EPSRC Centre for Doctoral Training in
Synthesis for Biology and Medicine (EP/L015838/1) for a
studentship to R.S. (Oxford University), generously supported
by AstraZeneca, Diamond Light Source, Defence Science and
Technology Laboratory, Evotec, GlaxoSmithKline, Janssen,
Novartis, Pfizer, Syngenta, Takeda, UCB, and Vertex. We also
acknowledge the Swiss National Foundation
(P2BSP2_178609, P.G.I., Oxford University), ERASMUS
(M.G., Oxford University), and the EPSRC (EP/R511742/1,
N.J.W.S., Oxford University) for funding. We acknowledge
Jeroen B. I. Sap (Oxford University) and Florian Guibbal
(Oxford University) for assistance with radiochemical experi-
ments. We also acknowledge Stephen Hyde (Oxford
University) for conducting preliminary experiments, Adeline
W. J. Poh (Oxford University) for synthesizing an
intermediate, and Eddie Toma (Oxford University) for
assistance using the glovebox.
REFERENCES
■
182.
(2) Wang, R.; Wang, L.; Zhang, K.; Li, J.; Zou, D.; Wu, Y.; Wu, Y.
D
Org. Lett. XXXX, XXX, XXX−XXX